Market Reports /
by Rachael Jones -
A month ago
30 Nov 2020 - The Australian share market failed to gain momentum today with the local bourse closing 1.3 per cent lower. Shares in Treasury Wine Estates (ASX:TWE) dropped today on…
Company News /
by Rachael Jones -
A month ago
30 Nov 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into an agreement with Scintec Diagnostics GmbH to acquire TheraPharm GmbH.
Market Reports /
by Michael Luu -
4 months ago
03 Sep 2020 - The Australian share market shot up at the open following strong performance levels on Wall Street, especially record highs on the Nasdaq and S&P 500. Australia has r…
Company News /
by Rachael Jones -
4 months ago
03 Sep 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement with California-based Varian Medical Systems.
Market Reports /
by Rachael Jones -
6 months ago
01 Jul 2020 - It has been a positive day of trade for the ASX in the first session of the new year, lifted by banks and gold miners to close 0.6% higher. As for the sectors today R…
Company News /
by Rachael Jones -
6 months ago
01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation for Telix’s renal cancer imag…
Market Reports /
by Ortenzia Borre -
8 months ago
15 May 2020 - The Australian share market rose at the open and continued to rally throughout the day, closing 0.4 per cent up at the end of trade.
Company News /
by Ortenzia Borre -
8 months ago
15 May 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a commercial distribution agreement with Boca Raton-based Pharmalogic.
Company Presentations /
by -
9 months ago
23 Apr 2020 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer, Dr. David Cade talks about the company's product pipeline, financials and strategy.
Interviews /
by Rachael Jones -
9 months ago
24 Apr 2020 - Telix Pharmaceuticals (ASX:TLX), Chief Business Officer, David Cade talks about its prostate cancer imaging product, diagnostic and therapeutic products, partners and…
Market Reports /
by Rachael Jones -
A year ago
23 Jan 2020 - It has been a negative day of trade for the ASX closing 0.6% lower. Shares shot up for National Storage REIT (ASX:NSR) after they confirmed they had received a takeov…
Market Reports /
by Rachael Jones -
A year ago
27 Dec 2019 - The ASX unfortunately is looking to take a dip after its break although Wall Street saw some movement in the opposite direction rising up in overnight trade. Wall Str…
Market Reports /
by Rachael Jones -
A year ago
23 Dec 2019 - The ASX took a dip at the open and has continued to fall throughout the morning now tracking 0.3% lower at noon. Jumbo (ASX:JIN) shares have fallen as have NearMap (A…
Company News /
by Katrina Bullock -
A year ago
20 Dec 2019 - Biopharmaceutical company, Telix Pharmaceuticals (ASX:TLX) is pleased to announce that Telix collaborator Professor Frédéric Hollande has been awarded a research gran…
Company News /
by Rachael Jones -
A year ago
07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of In…
Company News /
by Rachael Jones -
A year ago
03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with technology giant Eckert & Ziegler to acquire a radiopharmaceutical production f…
Interviews /
by Anna Napoli -
A year ago
30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefits of using its diagnostic and therap…
Company Presentations /
by -
A year ago
30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefit of diagnostic and therapeutic produ…
Company News /
by Katrina Bullock -
A year ago
26 Apr 2019 - Telix Pharmaceuticals (ASX:TLX) has announced that phase two of its prostate drug clinical data demonstrates that low, repeated doses significantly reduce hematologic…
Market Reports /
by Rachael Jones -
2 years ago
24 Jan 2019 - The ASX opened higher and is now tracking 0.2% higher at noon. Santos (ASX:STO) stock is one of the best performers today after announcing their record quarterly sale…
Market Reports /
by Anna Napoli -
2 years ago
08 Jan 2019 - Australian shares are expected to edge higher this morning following a rally on Wall Street. Biotech company, Telix Pharmaceuticals (ASX:TLX) has announced the accele…
Company News /
by Rachael Jones -
2 years ago
10 Oct 2018 - Biopharmaceutical company Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement with GenesisCare, the largest private provider of oncol…
Company News /
by Anna Napoli -
2 years ago
11 Sep 2018 - Telix Pharmaceuticals (ASX:TLX) has today announced the completion of its acquisition of Atlab Pharma.
Company News /
by Anna Napoli -
2 years ago
04 Sep 2018 - Biopharmaceutical company, Telix (ASX:TLX) has secured ethics approval to commence a Phase1/11 study for the use of its drug to treat recurrent glioblastoma.
Company News /
by Rachael Jones -
2 years ago
10 Aug 2018 - Biopharmaceutical company Telix Pharmaceuticals (ASX:TLX) has extended its agreement with Endocyte, Inc.